News
Teva Pharmaceutical Industries Ltd. Slashes Full-Year Outlook After Disappointing Second Quarter
Buying the Actavis Generics business from Allergan (NYSE: AGN) made the difference for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) when it reported first-quarter results in May. That deal boosted
Masimo Corporation Raises Full-Year Guidance After Second-Quarter Earnings Soar
Investors thoroughly enjoyed learning how Masimo Corporation (NASDAQ: MASI) performed in the first quarter back in May. The maker of non-invasive monitoring technologies reported impressive revenue
Globus Medical Enjoys Another Solid Quarter Thanks to International Sales Growth
So far, 2017 is shaping up to be the best year for Globus Medical (NYSE: GMED) shareholders in quite a while. The musculoskeletal implant manufacturer posted great numbers for the first quarter
Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales
Pacific Biosciences of California (NASDAQ: PACB) didn't fare so well the last time it provided a quarterly update. After the genetic-sequencing company reported its first-quarter results in late
ResMed Tops Expectations but Falls Anyway
Medical-device maker ResMed (NYSE: RMD) reported its fiscal fourth-quarter results after the market closed on Tuesday, Aug. 1. The continuous positive airway pressure (CPAP) pioneer reported modest
Restriktive und Expansive Geldpolitik – Beispiel Japan
Restriktive und Expansive Geldpolitik
Zuerst muss ich ein wenig ausholen. Nach der Finanzkrise im Jahr 2008 hat die amerikanische Notenbank FED ein großes Anleihekaufprogramm gestartet, um denn....
10 Reasons Illumina's Momentum Is Just Cranking Up
Illumina (NASDAQ: ILMN) knocked the ball out of the park with its second-quarter earnings results. Shares soared after the gene-sequencing pioneer blew away expectations for revenue and earnings
IDEXX Laboratories, Inc.'s Investors Look the Gift Horse in the Mouth
IDEXX Laboratories (NASDAQ: IDXX) reported solid revenue growth with operating income and earnings growing even faster allowing the animal diagnostic company to raise 2017 guidance.But investors
Illumina Soars After Crushing Expectations for Q2
In response an upbeat second-quarter report and bullish guidance, shares of Illumina (NASDAQ: ILMN), a leading provider of genetic testing equipment, rose Wednesday morning. The stock was up by 13.3%
3 Companies Building the World of Tomorrow
It's always intriguing to think about what new technologies the future will bring. But what you might not realize is that many of the building blocks of tomorrow are already in place. And lucky for
Illumina Inc. Blows Past Guidance in Second Quarter With Strong NovaSeq Demand
Illumina Inc. (NASDAQ: ILMN) started out 2017 on a positive note by beating its first-quarter revenue guidance and coming in at the upper end of its earnings guidance. However, there were a few
Medicrea annonce la première opération chirurgicale mini-invasive de la colonne vertébrale faisant appel à ses implants sur mesure UNiD
Medicrea annonce la première opération chirurgicale mini-invasive de la colonne vertébrale faisant appel à ses implants sur mesure
Lyon et New York, le 31 juillet 2017 – Le groupe Medicrea....
President Trump's Breaking of This 148-Year Streak Won't Slow This Trend One Bit
When Donald Trump entered the Oval Office, we knew things would be a bit different. After all, he's the first president ever to not have any military or political experience, and he's just the second
McCain Pulls the Plug on Obamacare "Skinny Repeal" Without Replacement
Republicans have been fighting to repeal and replace the Affordable Care Act since it was passed by Democrats in 2010. After winning Congress and the White House last November, many republicans
Here's Why Align Technology Marched Higher Again Today
Shares of Align Technology, Inc. (NASDAQ: ALGN), an orthodontic-device company, rose about 10% during Friday's session. Record results released after the bell on Thursday should keep investors smiling
Why Mednax Tumbled 12% Today Despite Higher Sales
Despite reporting 9.2% year-over-year sales growth, a sharp decline in profitability sent shares in Mednax (NYSE: MD) lower Friday. Shares were down 11.9% at noon EDT. Mednax is a large provider of
Abiomed, Inc. Starts Its Fiscal Year on a High Note
Abiomed (NASDAQ: ABMD), a medical-device company focused on minimally invasive heart pumps, reported its fiscal first-quarter earnings on Thursday, July 27. The company's results proved yet again that
Align Technology Again Makes Investors Smile With a Record Second Quarter
Align Technology's (NASDAQ: ALGN) first quarter was one for the record books. On Thursday, Align announced its second-quarter results. The orthodontic-device maker reported all-time high revenue
Executive Changes Hit NuVasive Hard
Advances in medical science have had a dramatic impact on the quality of care that patients receive. In the area of spinal surgery, NuVasive (NASDAQ: NUVA) has made a lot of headway with its minimally
Cerner Corporation Meets Expectations in Second Quarter With Solid Recurring Revenue
Cerner Corporation (NASDAQ: CERN) got off to a solid start in 2017 with its first-quarter results. The healthcare technology giant posted both revenue and earnings at the upper end of its guidance.On
Baxter International Inc.'s Revenue Growth Snoozes, but Check Out the Earnings Growth
Baxter (NYSE: BAX) kept with its trend in the second quarter of marginal revenue growth, but included a substantial improvement in spending, resulting in an increase in earnings that once again beat
Natus Medical Inc Looks to Turn Things Around
Natus Medical (NASDAQ: BABY) continued the trend from the first quarter of the year: Revenue came in substantially higher in the second quarter, due to the addition of revenue from the company's
Why Community Health Shares Are Crashing 15.6% Today
Only days after competitor HCA reported disappointing second-quarter results, Community Health Systems (NYSE: CYH) provided a peek at its own second-quarter performance. Unfortunately, the preliminary
Why Amedisys Is Crashing 14.3% Today
After the Centers for Medicare and Medicaid Services (CMS) said it may reduce reimbursement for home healthcare by 0.4% in 2018, shares in Amedisys Inc. (NASDAQ: AMED) are losing 14.3% of their value
BASTIDE : FINALISATION DE 5 ACQUISITIONS EN FRANCE ACCROISSEMENT DES PARTS DE MARCHE EN RESPIRATOIRE ET DEVELOPPEMENT DE LA VENTE EN LIGNE
Le Groupe Bastide Le Confort Médical annonce avoir finalisé 5 opérations de croissance externe en juillet en France, quatre dans le domaine des prestations de services en Assistance....